Dean Y Li Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Dean Y Li.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Dean Y Li. Dean Y Li is Executive VP & President, MRL in Merck & Co., Inc. ($MRK) and Director in RECURSION PHARMACEUTICALS, INC. ($RXRX).
Latest Insider Trading Transactions of Dean Y Li
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 06 2021 | MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & Pres ... | Option Exercise | M | 0.00 | 694 | 0 | 0 | |
| May 06 2021 | MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & Pres ... | Option Exercise | A | 75.99 | 91,837 | 6,978,694 | 91,837 | |
| May 06 2021 | MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & Pres ... | Payment of Exercise | F | 75.98 | 238 | 18,083 | 12,310 | 12.5 K to 12.3 K (-1.90 %) |
| May 06 2021 | MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & Pres ... | Buy | M | 75.98 | 694 | 52,730 | 12,548 | 11.9 K to 12.5 K (+5.85 %) |
| May 04 2021 | MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & Pres ... | Option Exercise | M | 0.00 | 750 | 0 | 750 | |
| May 04 2021 | MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & Pres ... | Option Exercise | M | 0.00 | 1,030 | 0 | 2,060 | |
| May 04 2021 | MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & Pres ... | Payment of Exercise | F | 74.50 | 257 | 19,147 | 11,854 | 12.1 K to 11.9 K (-2.12 %) |
| May 04 2021 | MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & Pres ... | Buy | M | 74.50 | 750 | 55,875 | 12,111 | 11.4 K to 12.1 K (+6.60 %) |
| May 04 2021 | MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & Pres ... | Payment of Exercise | F | 74.50 | 354 | 26,373 | 11,361 | 11.7 K to 11.4 K (-3.02 %) |
| May 04 2021 | MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & Pres ... | Buy | M | 74.50 | 1,030 | 76,735 | 11,715 | 10.7 K to 11.7 K (+9.64 %) |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Option Exercise | C | 0.00 | 32,685 | 0 | 0 | |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Option Exercise | C | 0.00 | 22,698 | 0 | 0 | |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Option Exercise | C | 18.00 | 27,778 | 500,004 | 27,778 | |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Option Exercise | C | 18.00 | 27,778 | 500,004 | 0 | |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Buy | J | 0.00 | 13,889 | 0 | 596,390 | 582.5 K to 596.4 K (+2.38 %) |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Sell | J | 0.00 | 13,889 | 0 | 0 | 13.9 K to 0 (-100.00 %) |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Buy | J | 0.00 | 582,501 | 0 | 582,501 | 0 to 582.5 K |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Sell | J | 0.00 | 582,501 | 0 | 0 | 582.5 K to 0 (-100.00 %) |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Buy | J | 0.00 | 1,350,000 | 0 | 1,350,000 | 0 to 1.4 M |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Sell | J | 0.00 | 1,350,000 | 0 | 0 | 1.4 M to 0 (-100.00 %) |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Buy | J | 0.00 | 450,000 | 0 | 450,000 | 0 to 450 K |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Sell | J | 0.00 | 450,000 | 0 | 0 | 450 K to 0 (-100.00 %) |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Buy | J | 0.00 | 1,422,048 | 0 | 1,422,048 | 0 to 1.4 M |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Sell | J | 0.00 | 1,422,048 | 0 | 0 | 1.4 M to 0 (-100.00 %) |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Buy | C | 0.00 | 55,383 | 0 | 1,422,048 | 1.4 M to 1.4 M (+4.05 %) |
| Apr 19 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Option Exercise | A | 18.00 | 27,778 | 500,004 | 27,778 | |
| Apr 19 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Grant | A | 0.00 | 13,889 | 0 | 596,390 | 582.5 K to 596.4 K (+2.38 %) |
| Mar 02 2021 | MRK | Merck & Co., Inc. | Li Dean Y | Executive VP & Pres ... | Grant | A | 72.62 | 3,485 | 253,081 | 10,655 | 7.2 K to 10.7 K (+48.61 %) |
Page: 1